CS242892B2 - Method of 1,4:3,6-dianhydrohexitol's derivatives production - Google Patents

Method of 1,4:3,6-dianhydrohexitol's derivatives production Download PDF

Info

Publication number
CS242892B2
CS242892B2 CS839976A CS997683A CS242892B2 CS 242892 B2 CS242892 B2 CS 242892B2 CS 839976 A CS839976 A CS 839976A CS 997683 A CS997683 A CS 997683A CS 242892 B2 CS242892 B2 CS 242892B2
Authority
CS
Czechoslovakia
Prior art keywords
dihydro
isosorbide
acetone
dimethyl
formula
Prior art date
Application number
CS839976A
Other languages
Czech (cs)
English (en)
Other versions
CS997683A2 (en
Inventor
Peter Stoss
Matyas Leitold
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of CS997683A2 publication Critical patent/CS997683A2/cs
Publication of CS242892B2 publication Critical patent/CS242892B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
CS839976A 1982-12-29 1983-12-27 Method of 1,4:3,6-dianhydrohexitol's derivatives production CS242892B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823248548 DE3248548A1 (de) 1982-12-29 1982-12-29 Acylderivate von 1,4:3,6-dianhydro-hexiten, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
CS997683A2 CS997683A2 (en) 1985-08-15
CS242892B2 true CS242892B2 (en) 1986-05-15

Family

ID=6182102

Family Applications (1)

Application Number Title Priority Date Filing Date
CS839976A CS242892B2 (en) 1982-12-29 1983-12-27 Method of 1,4:3,6-dianhydrohexitol's derivatives production

Country Status (11)

Country Link
US (1) US4559351A (hu)
EP (1) EP0114270B1 (hu)
JP (1) JPS59130887A (hu)
CA (1) CA1238048A (hu)
CS (1) CS242892B2 (hu)
DD (1) DD213925A5 (hu)
DE (2) DE3248548A1 (hu)
DK (1) DK602683A (hu)
HK (1) HK49188A (hu)
HU (1) HU195833B (hu)
PL (1) PL140341B1 (hu)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
FI880990A (fi) * 1987-03-05 1988-09-06 Yamanouchi Pharma Co Ltd Pyridinderivat, deras framstaellning, dessa innehaollande aemnen foer att skoeta och foerebygga leverskador, och metod foer att skoeta och foerebygga leverskador genom att anvaenda dessa aemnen.
DE3716652A1 (de) * 1987-05-19 1988-12-08 Bayer Ag Dioxyalkylenaryl-dihydropyridine, zwischenprodukte zu ihrer herstellung, verfahren zu ihrer herstellung und ihre verwendung
DE3831949A1 (de) * 1988-09-20 1990-03-22 Mack Chem Pharm Arzneimittel
DE3906267A1 (de) * 1989-02-28 1990-08-30 Mack Chem Pharm Pyridylcarboxyl-isosorbid-derivat
NL9001752A (nl) * 1990-08-02 1992-03-02 Cedona Pharm Bv Nieuwe 1,4-dihydropyridinederivaten.
NL9001955A (nl) * 1990-09-05 1992-04-01 Cedona Pharm Bv Nieuwe thiazolidinederivaten.
FR2680173A1 (fr) * 1991-08-07 1993-02-12 Hoechst Lab Nitrates organiques, leurs procedes de preparation et leur utilisation dans le traitement de maladies cardiovasculaires .
EP0881253A1 (en) * 1997-05-27 1998-12-02 Akcros Chemicals B-ketoesters for use as polymer stabilisers
ES2142773B1 (es) * 1998-10-07 2001-01-01 Lacer Sa Derivados de mononitrato de isosorbida y su empleo como agentes vasodilatadores con tolerancia desminuida.
US8496917B2 (en) * 2009-11-13 2013-07-30 Sytheon Ltd Compositions and methods for improving skin appearance
EP2755332B1 (en) 2011-09-09 2017-04-26 Sumitomo Electric Industries, Ltd. Power supply system and connector
WO2014062625A1 (en) * 2012-10-15 2014-04-24 Iowa State University Research Foundation, Inc. Tackifier compounds and methods of using the same
DK3273951T3 (da) 2015-03-27 2020-11-02 Symbionyx Pharmaceuticals Inc Sammensætninger og fremgangsmåder til behandling af psoriasis
US10597402B2 (en) 2015-03-27 2020-03-24 Sytheon Limited Compositions and methods for restoring epidermal integrity and function and treating dermatological diseases
US10077257B2 (en) 2015-04-06 2018-09-18 Iowa State University Research Foundation, Inc. Aziridinated triglycerides and polymers formed therefrom
US10392471B2 (en) 2015-05-14 2019-08-27 Iowa State University Research Foundation, Inc. Polymers and methods of making the same
US11529309B2 (en) * 2016-04-29 2022-12-20 University Of Houston System Compositions, methods and kits for treating a contact lens

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2143324A (en) * 1938-07-07 1939-01-10 Hynson Westcott & Dunning Inc Diuretic composition
GB1027891A (en) * 1962-01-02 1966-04-27 Aspro Nicholas Ltd Esters of dianhydro-hexitols
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
US3886186A (en) * 1971-04-29 1975-05-27 American Home Prod Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
AU465217B2 (en) * 1971-04-29 1975-09-18 American Home Products Corporation Mononitrte esters of 1,4:3, 6-dianhydro-d-glucitol
US4154839A (en) * 1975-11-05 1979-05-15 Bayer Aktiengesellschaft 2,6-Dimethyl-3-carboxymethoxy-4-(2-nitrophenyl)-5-carbisobutoxy-1,4-dihydropyridine
DE2650013C3 (de) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1.4-Dihydro-2.6-dimethyl-4-(3-nitrophenyl)-3.5-pyridindicarbonsäureisopropyl-(2-propoxy-äthyl)-ester, Verfahren zu seiner Herstellung sowie ihn enthaltende Arzneimittel
US4065488A (en) * 1977-02-24 1977-12-27 American Home Products Corporation Process for preparing 1,4:3,6-dianhydro-D-glucitol 2-nitrate
DE2935451A1 (de) * 1979-09-01 1981-03-19 Bayer Ag, 5090 Leverkusen Optisch aktive 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arneimittel
DE2938464A1 (de) * 1979-09-22 1981-04-09 Bayer Ag, 5090 Leverkusen Thermoplastische polycarbonate, ihre herstellung und ihre verwendung als formkoerper und folien
DE3028289C2 (de) * 1980-07-25 1986-11-27 Dr. Willmar Schwabe GmbH & Co, 7500 Karlsruhe 2-O- und 5-O-substituierte 1.4;3.6-Dianhydro-hexit-mononitrate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
DE3111092A1 (de) * 1981-03-20 1982-09-30 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1.4-3.6-dianhydro-hexitolen
DE3119553A1 (de) * 1981-05-16 1982-12-02 Hoechst Ag, 6000 Frankfurt "verfahren zur herstellung von carbonsaeureestern von anhydrohexiten"
DE3128102A1 (de) * 1981-07-16 1983-02-03 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung von isosorbid-2-acylaten

Also Published As

Publication number Publication date
US4559351A (en) 1985-12-17
EP0114270A1 (de) 1984-08-01
HUT35268A (en) 1985-06-28
DD213925A5 (de) 1984-09-26
JPS635035B2 (hu) 1988-02-01
HU195833B (en) 1988-07-28
DE3370629D1 (en) 1987-05-07
EP0114270B1 (de) 1987-04-01
PL245404A1 (en) 1985-03-12
CA1238048A (en) 1988-06-14
JPS59130887A (ja) 1984-07-27
HK49188A (en) 1988-07-15
DE3248548A1 (de) 1984-07-05
PL140341B1 (en) 1987-04-30
CS997683A2 (en) 1985-08-15
DK602683A (da) 1984-06-30
DK602683D0 (da) 1983-12-28

Similar Documents

Publication Publication Date Title
CS242892B2 (en) Method of 1,4:3,6-dianhydrohexitol's derivatives production
RU2158733C2 (ru) Производные 2,8-дизамещенного хиназолинона или их соли, фармацевтическая композиция с воздействующей на уровень кгмп и камп активностью на их основе
FI61696C (fi) Foerfarande foer framstaellning av vasodilatoriska 1,4-dihydropyridinderivat
EP0359036B1 (en) Fumagillol derivatives
KR20050030958A (ko) 신규한 1Ｈ-이미다조[4,5-ｃ]퀴놀린-4-시아노 및1Ｈ-이미다조[4,5-ｃ]퀴놀린-4-카르복스아미드 중간체를통한 1Ｈ-이미다조[4,5-ｃ]퀴놀린-4-아민의 제조 방법
WO1987002668A1 (en) Novel pharmacological compounds
JPS63253082A (ja) ジヒドロピリジン誘導体
US4847379A (en) 3,6-dihydro-1,5(2H)-pyrimidinecarboxylic acid esters
PT97422A (pt) Metodo para a utilizacao de acidos hidroxamicos e n-hidroxi-ureias como anti-inflamatorios e metodo para a sua producao
SK106595A3 (en) Substituted derivatives of 4-phenyl-6-amino-nicotinic acid, mnufacturing process thereof, drugs containing these substances and their use
SU1395143A3 (ru) Способ получени производных 1,6-нафтиридина в виде рацематов или энантиомеров,или их кислотно-аддитивных солей
US4883872A (en) 3-oxo-1,2,4-triazolo(4,3-A) pyrimidine-6-carboxylic acid esters
EP1042326B1 (fr) Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HU191784B (en) Process for production of tetrahydro-tieno-piridin-derivatives and medical preparatives containing of such compounds
EP0207674B1 (en) 1,4-dihydropyridine derivatives, their preparation and their pharmaceutical use
EP2163553B1 (en) Arene connected polyamine macroring derivatives, preparation methods and pharmaceutical uses thereof
KR950005198B1 (ko) 퀴논 유도체
HU193785B (en) Process for producing dihydropyridine derivatives
EP1061081B1 (fr) Nouveaux dérivés de carboxylate de 7-oxo-2,3,7,14-tétrahydro-1H-benzo(b)pyrano(3,2-h)acridine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0290885A2 (en) 1,4:3,6-Dianhydrosorbitol 2-mono-nitrate and 5-mononitrate esters, a process for the preparation thereof and pharmaceutical compositions therefrom
EP0083256B1 (en) Benzamide derivatives
US3562272A (en) Preparation of 4-aryl-2(1h)-quinazolinones
FI85483C (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara av 1,4:3,6-dianhydrohexitolderivat.
KR920003626B1 (ko) 디히드로피리딘-3,5-디카르복실산 에스테르 유도체의 제조방법
EP1561753A2 (fr) Dérivés de benzo[b]chroménonapthyridin-7-one et de pyrano[2',3':7,8]quino[2,3-b]quinoxalin-7-one, leur procédé de préparation, les compositions pharmaceutiques qui les contiennent et leurs propriétés antitumorales pour le traitement du cancer